Business Standard

Opportunity in adversity

Indias twin deficits are at elevated levels. The July-Sep CAD was at an alarming 5.4%, while the fiscal deficit touched 80% of the full-year target by November-end

Sonam Udasi 

>

Opportunity in adversity
India

RECOMMENDED FOR YOU

Opportunity in adversity

Indias twin deficits are at elevated levels. The July-Sep CAD was at an alarming 5.4%, while the fiscal deficit touched 80% of the full-year target by November-end

2012 has been a good year for the Indian markets, with Nifty gains of 24 per cent. The broader market, in fact, outpaced benchmark indices. The CNX Midcap gained 36 per cent and the CNX Smallcap 32 per cent. The year saw foreign institutional investors (FIIs) pour in $24 billion. At the start of the year, not many could have anticipated such strength. Gross domestic product (GDP) growth for much of 2012 has been in the sub-5.5 per cent range and inflation showed no sign of cooling meaningfully. But, then, such is the wisdom of markets. It tends to climb walls of worries and see opportunity in adversity. >
Opportunity in adversity
India image

LIVE MARKET

BSE

  ( %)

NSE

  ( %)

Widgets Magazine

More News

STOCK WATCH

Company Price() Chg(%)
Take Solutions 154.85 19.99
Vijaya Bank 34.30 15.88
Sequent Scien. 864.25 15.19
Jindal Steel 63.45 10.44
Yamini Invest 46.65 9.64
> More on BSE Gainers
Company Price() Chg(%)
Vijaya Bank 34.25 16.10
Federal-Mogul Go 339.10 12.06
Jindal Steel 63.50 10.63
Suzlon Energy 15.75 9.38
Lupin 1802.85 9.08
> More on NSE Gainers
Company Price() Chg(%)
SE Investments 181.10 -7.01
Alembic Pharma 596.55 -5.77
Crompton Greaves 126.90 -5.33
ISGEC Heavy 4484.50 -5.12
Bosch 16133.20 -4.97
> More on BSE Gainers
Company Price() Chg(%)
Alembic Pharma 593.20 -6.33
Bosch 16089.10 -5.24
Ess Dee Alumin. 165.15 -4.98
Zydus Wellness 700.00 -4.68
J B Chem & Pharm 256.95 -4.46
> More on NSE Gainers
Widgets Magazine
Widgets Magazine
Widgets Magazine

Derivatives

Index
Instrument Type
Expiry Date
Option Type
Strike Price